Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 158

Sort by

Sort Order Select

Journal Articles

High-Dose Cytarabine with Idarubicin Versus High-Dose Cytarabine within First Consolidation for Acute Myeloid Leukemia in First Complete Remission: An Open-Label, Multicenter, Randomized, Phase 3 Trial

Zinan Feng, Yu Zhang, Hui Liu, Sijian Yu, Qifa Liu, Li Xuan

Blood (2024) 144 (Supplement 1): 972.

https://doi.org/10.1182/blood-2024-200583

Published: 2024

Journal Articles

Updated Outcome from Biomarker MSC-C5b-9-Guided All-Trans Retinoic Acid Treatment for Resistant/Recurrent ITP: A Multicenter, Randomized, Open-Label, Phase 3 Clinical Trial

Menglin Li, HaiXia Fu, Hui Liu, Ru Feng, Yi Liu, Jingwen Wang, Lei Yang, Zhao Wang, Gaochao Zhang, Qingyuan Qu, Yuxiu Chen, Jianying Zhou, Mengyu Xiao, Lulu Wang, Mengtong Zang, Yun He, Xiaolu Zhu, Xiaosu Zhao, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 712.

https://doi.org/10.1182/blood-2024-198335

Published: 2024

Journal Articles

Lower Respiratory Tract Pathogen Colonization Detected By Metagenomic Next-Generation Sequencing of Bronchoalveolar Lavage Fluid before Allogeneic Hematopoietic Stem Cell Transplantation and Its Predicting Value for Post-Transplant Infection

Hang Zhang, Hui Liu, Ting Liu, Ting Niu, Zhigang Liu, Jie Ji

Blood (2024) 144 (Supplement 1): 3512.

https://doi.org/10.1182/blood-2024-209691

Published: 2024

Journal Articles

Sorafenib Combined with Chemotherapy and Donor Lymphocyte Infusion for Patients with FLT3 Wild-Type Acute Leukemia Relapsing after Allo-HSCT

Tian Zhang, Peiru Chi, Zhiping Fan, Na Xu, Hui Xu, Fen Huang, Ren Lin, Zhixiang Wang, Hui Liu, Xueying Ou, Ke Zhao, Ling Jiang, Jing Sun, Qifa Liu, Li Xuan

Blood (2024) 144 (Supplement 1): 7385.

https://doi.org/10.1182/blood-2024-203334

Published: 2024

Journal Articles

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT ± MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Label, Multicenter Clinical Trial

Rong Fu, Jia Song, Hui Liu, Zongjiu Jiao, Da Gao, Kai Ding, Jie Zhuo, Huijuan Jiang, Shan Gao, Yue Ren, Lijuan Li, Yihao Wang

Blood (2024) 144 (Supplement 1): 7786.

https://doi.org/10.1182/blood-2024-209056

Published: 2024

Journal Articles

Increased EBV Infection and Relapse Rates Following Haploidentical Hematopoietic Cell Transplantation in the Era of Letermovir for Cytomegalovirus Prophylaxis: A Propensity Score Matching Analysis

Yifei Huang, Ren Lin, Shanyu Zhang, Zhiping Fan, Fen Huang, Li Xuan, Na Xu, Hui Liu, Zhixiang Wang, Min Dai, Hua Jin, Jing Sun, Qifa Liu

Blood (2024) 144 (Supplement 1): 4923.

https://doi.org/10.1182/blood-2024-202355

Published: 2024

Journal Articles

Combination of Mitoxantrone Hydrochloride Liposome with Gemcitabine, Cisplatin and Dexamethasone in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma: A Phase I Study

Chong Wei, Shengyu Zhou, Shuangnian Xu, Hongmei Jing, Hui Liu, Wei Zhang, Daobin Zhou

Blood (2024) 144 (Supplement 1): 1691.

https://doi.org/10.1182/blood-2024-209576

Published: 2024

Journal Articles

Subgroup Analyses of Phase 2 Study: Evaluating the Efficacy of Fully Human BCMA-Targeting CAR T Cells (Zevorcabtagene Autoleucel) in Patients with Relapsed/Refractory Multiple Myeloma

Blood (2024) 144 (Supplement 1): 4762.

https://doi.org/10.1182/blood-2024-204620

Published: 2024

Journal Articles

Genetic Characteristics of Patients Aged ≥80 Years with Diffuse Large B-Cell Lymphoma

Xiaoya Yun, Jiefei Bai, Ru Feng, Hongmei Jing, Hui Liu

Blood (2024) 144 (Supplement 1): 6228.

https://doi.org/10.1182/blood-2024-207720

Published: 2024

Journal Articles

Real-World Clinical Outcomes of Daratumumab-Based Regimens in Chinese Patients with Multiple Myeloma By Cytogenetic Risk: A Subgroup Analysis of the MMY4032 Study

Luqun Wang, Wei Yang, Ting Niu, Yafei Wang, Rong Fu, Yuping Zhong, Kaiyang Ding, Kai Sun, Baijun Fang, Hong Liu, Wenbin Qian, Hui Liu, Yanhui Li, Yishen Yang, Jianmin Zhuo, Xi Chen, Canchan Cui, Jin Lu

Blood (2024) 144 (Supplement 1): 7874.

https://doi.org/10.1182/blood-2024-201134

Published: 2024

Journal Articles

Polatuzumab Vedotin Plus Anti-CD20 Monoclonal Antibody and Dexamethasone in Previously Untreated Very Old/Frail Patients with Diffuse Large B-Cell Lymphoma

Xiaoya Yun, Jiefei Bai, Ru Feng, Jiangtao Li, Ting Wang, Yazi Yang, Jingjing Yin, Long Qian, Weidong Ding, Xiaoxuan Xue, Haoyu Qin, Hongmei Jing, Hui Liu

Blood (2024) 144 (Supplement 1): 6521.

https://doi.org/10.1182/blood-2024-203031

Published: 2024

Journal Articles

Efficacy and Safety of Venetoclax Combine Azacitidine for Acute Myeloid Leukemia in China: A Real-World Single-Center Study

Jiefei Bai, Hui Liu, Jiangtao Li, Ting Wang, Chunli Zhang, Yazi Yang, Xiaoya Yun, Jingjing Yin, Long Qian, Fei Zhao, Ru Feng, Hongmei Jing

Blood (2024) 144 (Supplement 1): 7896.

https://doi.org/10.1182/blood-2024-193714

Published: 2024

Journal Articles

Long-Term Efficacy and Safety of CD19-Specific CAR-T Cells Armed with IL-7 and CCL19 in Patients with Relapsed or Refractory Large B-Cell Lymphoma: A Multi-Center Prospective Study

Wenbin Qian, Hui Liu, Wen Lei, Linqin Wang, Panpan Chen

Blood (2024) 144 (Supplement 1): 2087.

https://doi.org/10.1182/blood-2024-205376

Published: 2024

Journal Articles

Single-Cell Sequencing Reveals Differential Erythroid Lineage Differentiation in Patients with PNH

Junshu Wu, Hui Liu, Liyan Li, Wei Wang, Zhaoyun Liu, Rong Fu

Blood (2024) 144 (Supplement 1): 1078.

https://doi.org/10.1182/blood-2024-208178

Published: 2024

Journal Articles

Safety and Feasibility of a 41BB Co-Stimulated CD19 CAR-NK Cell Therapy in Refractory/Relapsed Large B-Cell Lymphoma

Wenbin Qian, Wen Lei, Hui Liu, Wei Chen, Yun Liang, Yi Eve Sun, Xiangmin Tong, Aibin Liang

Blood (2024) 144 (Supplement 1): 7209.

https://doi.org/10.1182/blood-2024-202988

Published: 2024

Journal Articles

Overexpression of GAD1 in Pediatric Acute Myeloid Leukemia Cells Impairs Cytotoxic T Lymphocyte Response to Tumor Cells

Xiaoxiao Chen, Bowen Cui, Shuang Zhao, Kefei Wu, Yangyang Xie, Hui Liu, Jiaoyang Cai, Xiang Wang, Yixiao Mo, Wenting Hu, Changcheng Chen, Han Wang, Ronghua Wang, Huiying Sun, Jianan Rao, Wenyan Wu, Yu Liu, Shuhong Shen

Blood (2024) 144 (Supplement 1): 4319.

https://doi.org/10.1182/blood-2024-206639

Published: 2024

Journal Articles

Spectrum and Clinical Features of Gene Mutations in Chinese Follicular Lymphoma

Chunyuan Li, Jingjing Yin, Yue Yuan, Ping Yang, Hui Liu, Hongmei Jing

Blood (2023) 142 (Supplement 1): 4418.

https://doi.org/10.1182/blood-2023-181497

Published: 2023

Journal Articles

Biomarker MSC-C5b-9-Guided Master Therapies for Resistant/Recurrent ITP: A Prospective, Randomized, Open-Label, Multicenter Trial

Menglin Li, Haixia Fu, Yi Liu, Hui Liu, Ru Feng, Zhao Wang, Jingwen Wang, Yuxiu Chen, Qingyuan Qu, Mengyu Xiao, Jianying Zhou, Yun He, Xiaolu Zhu, Yuan Kong, Yingjun Chang, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 3951.

https://doi.org/10.1182/blood-2023-182669

Published: 2023

Journal Articles

Genomic Landscape of Pediatric Non-Down's Syndrome Acute Megakaryoblastic Leukemia in China

Blood (2023) 142 (Supplement 1): 4331.

https://doi.org/10.1182/blood-2023-181798

Published: 2023

Journal Articles

Real-World Analysis of Treatment Patterns and the Effectiveness and Safety Profile of Daratumumab-Based Regimens in Chinese Patients with Newly Diagnosed or Relapsed/Refractory Multiple Myeloma

Luqun Wang, Wei Yang, Yafei Wang, Ting Niu, Rong Fu, Yuping Zhong, Wenbin Qian, Kaiyang Ding, Kai Sun, Hong Liu, Baijun Fang, Hui Liu, Yanhui Li, Yishen Yang, Jianmin Zhuo, Xi Chen, Canchan Cui, Jin Lu

Blood (2023) 142 (Supplement 1): 6635.

https://doi.org/10.1182/blood-2023-180948

Published: 2023

NARROW

High-Dose Cytarabine with Idarubicin Versus High-Dose Cytarabine within First Consolidation for Acute Myeloid Leukemia in First Complete Remission: An Open-Label, Multicenter, Randomized, Phase 3 Trial

Updated Outcome from Biomarker MSC-C5b-9-Guided All-Trans Retinoic Acid Treatment for Resistant/Recurrent ITP: A Multicenter, Randomized, Open-Label, Phase 3 Clinical Trial

Lower Respiratory Tract Pathogen Colonization Detected By Metagenomic Next-Generation Sequencing of Bronchoalveolar Lavage Fluid before Allogeneic Hematopoietic Stem Cell Transplantation and Its Predicting Value for Post-Transplant Infection

Sorafenib Combined with Chemotherapy and Donor Lymphocyte Infusion for Patients with FLT3 Wild-Type Acute Leukemia Relapsing after Allo-HSCT

Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT ± MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Label, Multicenter Clinical Trial

Increased EBV Infection and Relapse Rates Following Haploidentical Hematopoietic Cell Transplantation in the Era of Letermovir for Cytomegalovirus Prophylaxis: A Propensity Score Matching Analysis

Combination of Mitoxantrone Hydrochloride Liposome with Gemcitabine, Cisplatin and Dexamethasone in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma: A Phase I Study

Subgroup Analyses of Phase 2 Study: Evaluating the Efficacy of Fully Human BCMA-Targeting CAR T Cells (Zevorcabtagene Autoleucel) in Patients with Relapsed/Refractory Multiple Myeloma

Genetic Characteristics of Patients Aged ≥80 Years with Diffuse Large B-Cell Lymphoma

Real-World Clinical Outcomes of Daratumumab-Based Regimens in Chinese Patients with Multiple Myeloma By Cytogenetic Risk: A Subgroup Analysis of the MMY4032 Study

Polatuzumab Vedotin Plus Anti-CD20 Monoclonal Antibody and Dexamethasone in Previously Untreated Very Old/Frail Patients with Diffuse Large B-Cell Lymphoma

Efficacy and Safety of Venetoclax Combine Azacitidine for Acute Myeloid Leukemia in China: A Real-World Single-Center Study

Long-Term Efficacy and Safety of CD19-Specific CAR-T Cells Armed with IL-7 and CCL19 in Patients with Relapsed or Refractory Large B-Cell Lymphoma: A Multi-Center Prospective Study

Single-Cell Sequencing Reveals Differential Erythroid Lineage Differentiation in Patients with PNH

Safety and Feasibility of a 41BB Co-Stimulated CD19 CAR-NK Cell Therapy in Refractory/Relapsed Large B-Cell Lymphoma

Overexpression of GAD1 in Pediatric Acute Myeloid Leukemia Cells Impairs Cytotoxic T Lymphocyte Response to Tumor Cells

Spectrum and Clinical Features of Gene Mutations in Chinese Follicular Lymphoma

Biomarker MSC-C5b-9-Guided Master Therapies for Resistant/Recurrent ITP: A Prospective, Randomized, Open-Label, Multicenter Trial

Genomic Landscape of Pediatric Non-Down's Syndrome Acute Megakaryoblastic Leukemia in China

Real-World Analysis of Treatment Patterns and the Effectiveness and Safety Profile of Daratumumab-Based Regimens in Chinese Patients with Newly Diagnosed or Relapsed/Refractory Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only